Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation

NACompletedINTERVENTIONAL
Enrollment

1,528

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

August 23, 2022

Study Completion Date

August 23, 2022

Conditions
Coronary DiseaseCoronary Stenoses
Interventions
DEVICE

quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent

In the quantitative coronary angiography-guided group, sirolimus-eluting Orsiro/Orsiro mission stent size and length is chosen to cover the entire length of the culprit lesions according to quantitative coronary angiography measurements. Selection of the sirolimus-eluting Orsiro/Orsiro mission stent size should be guided by both quantitative coronary angiography measurement and visual estimate, and is recommended to be based on distal reference vessel diameter by quantitative coronary angiography (distal reference vessel diameter by quantitative coronary angiography plus \~10% of distal reference vessel diameter).

DEVICE

intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent

In the intravascular ultrasound -guided group, sirolimus-eluting Orsiro/Orsiro mission stent size and length is selected by intravascular ultrasound measurements.

Trial Locations (6)

Unknown

Korea University Anam Hospital, Anam

Hallym University Medical Center, Gyeonggi-do

National Health Insurance Service Ilsan Hospital, Ilsan

Asan Medical Center, Seoul

Gangnam Severance Christian Hospital, Seoul

Kangbuk Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Biotronik SE & Co. KG

INDUSTRY

lead

CHEOL WHAN LEE, M.D., Ph.D

OTHER

NCT02978456 - Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation | Biotech Hunter | Biotech Hunter